Paper42700331
Recent advancements in NRF2-regulated ferroptosis modulation for targeted cancer therapy.
Ulker OC and 5 others. Mol Biol Rep, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Recent advancements in NRF2-regulated ferroptosis modulation for targeted cancer therapy. Papers, record 42700331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42700331
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recent advancements in NRF2-regulated ferroptosis modulation for targeted cancer therapy.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ferroptosis | Major topic |
| NF-E2-Related Factor 2 | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Signal Transduction | |
| Animals | |
| Lipid Peroxidation | |
| Oxidative Stress | |
| Iron | |
| Molecular Targeted Therapy | |
| Drug Resistance, Neoplasm |
Source PubMed
References152
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27552339 | Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors. | ACS Chem Biol | 2016 | https://conductscience.org/library/papers/27552339 | PubMed |
| 2 | 40041932 | Randomized Phase II Clinical Trial of Sulforaphane in Former Smokers at High Risk for Lung Cancer. | Cancer Prev Res (Phila) | 2025 | https://conductscience.org/library/papers/40041932 | PubMed |
| 3 | 37217183 | Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study. | Blood | 2023 | https://conductscience.org/library/papers/37217183 | PubMed |
| 4 | 20512470 | Effect of stable inhibition of NRF2 on doxorubicin sensitivity in human ovarian carcinoma OV90 cells. | Arch Pharm Res | 2010 | https://conductscience.org/library/papers/20512470 | PubMed |
| 5 | 31595562 | Recent Progress in Ferroptosis Inducers for Cancer Therapy. | Adv Mater | 2019 | https://conductscience.org/library/papers/31595562 | PubMed |
| 6 | 29274359 | Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis. | Cancer Lett | 2018 | https://conductscience.org/library/papers/29274359 | PubMed |
| 7 | 36909174 | Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/36909174 | PubMed |
| 8 | 34843044 | A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies. | Target Oncol | 2022 | https://conductscience.org/library/papers/34843044 | PubMed |
| 9 | 28665143 | Suppression of Lipogenesis via Reactive Oxygen Species-AMPK Signaling for Treating Malignant and Proliferative Diseases. | Antioxid Redox Signal | 2018 | https://conductscience.org/library/papers/28665143 | PubMed |
| 10 | 41461245 | Integrating multi-omics and artificial intelligence fuels advanced target identification and drug discovery. | Biotechnol Adv | 2026 | https://conductscience.org/library/papers/41461245 | PubMed |
| 11 | 36453238 | Triptolide promotes ferroptosis by suppressing Nrf2 to overcome leukemia cell resistance to doxorubicin. | Mol Med Rep | 2023 | https://conductscience.org/library/papers/36453238 | PubMed |
| 12 | 38561058 | Esculin induces endoplasmic reticulum stress and drives apoptosis and ferroptosis in colorectal cancer via PERK regulating eIF2α/CHOP and Nrf2/HO-1 cascades. | J Ethnopharmacol | 2024 | https://conductscience.org/library/papers/38561058 | PubMed |
| 13 | 40911942 | RNF217-KEAP1-NRF2 feedback loop confers therapeutic resistance by inhibiting ferroptosis in esophageal squamous cell carcinoma. | Drug Resist Updat | 2025 | https://conductscience.org/library/papers/40911942 | PubMed |
| 14 | 30339884 | Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer. | Free Radic Biol Med | 2018 | https://conductscience.org/library/papers/30339884 | PubMed |
| 15 | 38663476 | Brusatol hinders the progression of bladder cancer by Chac1/Nrf2/SLC7A11 pathway. | Exp Cell Res | 2024 | https://conductscience.org/library/papers/38663476 | PubMed |
| 16 | 27002157 | Translation Regulation of the Glutamyl-prolyl-tRNA Synthetase Gene EPRS through Bypass of Upstream Open Reading Frames with Noncanonical Initiation Codons. | J Biol Chem | 2016 | https://conductscience.org/library/papers/27002157 | PubMed |
| 17 | 37237486 | PI3K/AKT/mTOR Signaling Pathway in HPV-Driven Head and Neck Carcinogenesis: Therapeutic Implications. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/37237486 | PubMed |
| 18 | 29717933 | The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis. | Physiol Rev | 2018 | https://conductscience.org/library/papers/29717933 | PubMed |
| 19 | 36994475 | Anti-Ferroptotic Effects of Nrf2: Beyond the Antioxidant Response. | Mol Cells | 2023 | https://conductscience.org/library/papers/36994475 | PubMed |
| 20 | 26403645 | Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. | Hepatology | 2016 | https://conductscience.org/library/papers/26403645 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| NFE2L2 | 4780 | PubTator's text mining | https://conductscience.org/library/genes/4780 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42700331
GET https://conductscience.org/api/papers/v1/42700331/references?page=2